CMA Microdialysis gets CE marking for ISCUS:
This article was originally published in Clinica
Swedish firm CMA Microdialysis has CE marked for sale in Europe its portable, bedside analyser, ISCUS. The device monitors the tissue biochemistry of vital organs by measuring levels of glucose, lactate, pyruvate and glycerol collected from a microdialysis catheter. ISCUS was designed for use in the intensive care setting, the Stockholm-based company says.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.